Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological perspectives.
Diabetes Mellitus (DM) is the fastest growing metabolic disorder affecting about 387 million people across the globe and is estimated to affect 592 million people by year 2030. The search for newer anti-diabetic agents is the foremost need to control the ..... Read More